Andersen-Tawil syndrome historical perspective: Difference between revisions
Jump to navigation
Jump to search
m Bot: Adding CME Category::Cardiology |
|||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
It is named for Ellen Andersen<ref>{{cite journal |author=Andersen ED, Krasilnikoff PA, Overvad H |title=Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome? |journal=Acta paediatrica Scandinavica |volume=60 |issue=5 |pages=559-64 |year=1971 |pmid=4106724|doi=}}</ref>and R. Tawil.<ref name="pmid8080508">{{cite journal |author=Tawil R, Ptacek LJ, Pavlakis SG, ''et al'' |title=Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features |journal=Ann. Neurol. |volume=35 |issue=3 |pages=326-30 |year=1994|pmid=8080508|doi=10.1002/ana.410350313}}</ref><ref>{{WhoNamedIt|synd|3410}}</ref> | It is named for Ellen Andersen<ref>{{cite journal |author=Andersen ED, Krasilnikoff PA, Overvad H |title=Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome? |journal=Acta paediatrica Scandinavica |volume=60 |issue=5 |pages=559-64 |year=1971 |pmid=4106724|doi=}}</ref>and R. Tawil.<ref name="pmid8080508">{{cite journal |author=Tawil R, Ptacek LJ, Pavlakis SG, ''et al'' |title=Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features |journal=Ann. Neurol. |volume=35 |issue=3 |pages=326-30 |year=1994|pmid=8080508|doi=10.1002/ana.410350313}}</ref><ref>{{WhoNamedIt|synd|3410}}</ref> | ||
== Historical Perspective == | |||
=== Discovery === | |||
* There is limited information about the historical perspective of [disease name]. | |||
OR | |||
* [Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event]. | |||
* The association between [important risk factor/cause] and [disease name] was made in/during [year/event]. | |||
* In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name]. | |||
* In [year], [gene] mutations were first implicated in the pathogenesis of [disease name]. | |||
=== Landmark Events in the Development of Treatment Strategies === | |||
=== Impact on Cultural History === | |||
=== Famous Cases === | |||
The following are a few famous cases of [disease name]: | |||
==References== | ==References== | ||
Revision as of 15:04, 27 January 2020
|
Andersen-Tawil syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Andersen-Tawil syndrome historical perspective On the Web |
|
American Roentgen Ray Society Images of Andersen-Tawil syndrome historical perspective |
|
Risk calculators and risk factors for Andersen-Tawil syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]; Raviteja Guddeti, M.B.B.S. [3]
Overview
It is named for Ellen Andersen[1]and R. Tawil.[2][3]
Historical Perspective
Discovery
- There is limited information about the historical perspective of [disease name].
OR
- [Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
- The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
- In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
- In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
Landmark Events in the Development of Treatment Strategies
Impact on Cultural History
Famous Cases
The following are a few famous cases of [disease name]:
References
- ↑ Andersen ED, Krasilnikoff PA, Overvad H (1971). "Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome?". Acta paediatrica Scandinavica. 60 (5): 559–64. PMID 4106724.
- ↑ Tawil R, Ptacek LJ, Pavlakis SG; et al. (1994). "Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features". Ann. Neurol. 35 (3): 326–30. doi:10.1002/ana.410350313. PMID 8080508.
- ↑ Template:WhoNamedIt